processing
Johnson & Johnson: Undervalued and Looking Good
Greg Speicher submits: Johnson & Johnson ( JNJ ) was formed in 1886. Over the past one-hundred and twenty-five years, it has produced an enviable record of growth and profitability and has grown into a diversified global giant with three main operating segments: consumer products, pharmaceuticals, and medical devices and diagnostics. 2009 sales were $61.9 billion with operating profits of $16.6 billion
Altermune – Real Stuff or Not?
Kary Mullis is an outlier among Nobel Prize winners.
Angiogenesis Inhibitors: Helping or Hurting?
Now, here’s something to think about: can angiogenesis inhibitors, the famous class of tumor-starving cancer drugs, actually make some kinds of cancer worse?





